HOLDING(S) IN COMPANY

Faron Pharmaceuticals Oy

22/04/2026 12:30

Faron Pharmaceuticals Ltd | Company announcement | April 22, 2026 at 14:30:00 EEST

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:
Faron Pharmaceuticals OY
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
X
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii:
3. Details of person subject to the notification obligationiv
Name
Heights Capital Management, Inc.
City and country of registered office (if applicable)
San Francisco, California
4. Full name of shareholder(s) (if different from 3.) v
Name
CVI Investments, Inc.
City and country of registered office (if applicable)
Cayman Islands
5. Date on which the threshold was crossed or reachedvi:
17/04/2026
6. Date on which issuer notified (DD/MM/YYYY):
20/04/2026
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)
% of voting rights through financial instruments
 (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached
10.00%
15.44%
25.44%
51,660,099
Position of previous notification (if
 applicable)
10.13%
15.44%
25.58%



8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type ofshares
 ISIN code (if possible)
Number of voting rightsix
% of voting rights
Direct
(DTR5.1)
Indirect
(DTR5.2.1)
Direct
(DTR5.1)
Indirect
(DTR5.2.1)
20,300,099
31,360,000
10.00%
15.44%
SUBTOTAL 8. A
51,660,099
25.44%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument
Expirationdatex
Exercise/Conversion Periodxi
Number of voting rights that may be acquired if the instrument is
exercised/converted.
% of voting rights
Convertible Bond
08/02/2027
Anytime until maturity
13,440,000
6.62%
Convertible Bond
12/02/2028
Anytime until maturity
17,920,000
8.83%
SUBTOTAL 8. B 1
31,360,000
15.44%
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument
Expirationdatex
Exercise/Conversion Periodxi
Physical or cash
Settlementxii
Number of voting rights
% of voting rights
SUBTOTAL 8.B.2


9. Information in relation to the person subject to the notification obligation (please mark the
 applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii
Full chain of controlled undertakings through which the voting rights and/or the
 financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv
Namexv
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
Heights Capital Management, Inc.
10.00%
15.44%
25.44%
CVI Investments, Inc.
10.00%
15.44%
25.44%
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional informationxvi
None

Place of completion
London, United Kingdom
Date of completion
20.04.2026